Invenesis Sàrl is a swiss biotechnology company based in Neuchâtel. We provide R&D services for drug discovery to industrial partners in the Animal Health, Plant Protection (Crop) and Pharmaceutical fields as well as Academia.
We are an agile structure offering electrophysiology (on Xenopus oocytes and invertebrates) and organism-based (model organisms and parasitology) platforms to look for drugs, pheromones, bio-control and biologics with applications in parasitology, agriculture and human medicine.
We provide the Science and the Technologies allowing you to screen chemical compounds and generate your own Intellectual Property.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Invenesis Sàrl,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.invenesis.com
- Keywords
- electrophysiology, screening, drug discovery, parasitology, phenotypic assays, biotechnology, machine vision, model organisms, ion channels, behavioural assays, organism-based assays.
- HQ
- St-Blaise, Neuchâtel
Invenesis Questions
Invenesis's website is http://www.invenesis.com
Invenesis's LinkedIn profile is https://www.linkedin.com/company/invenesis
Invenesis has
13 employees.
View email and phone details for 13
employees at Invenesis.
Invenesis's industry is
Biotechnology Research
Invenesis's top competitors are
Celluminova,
Shanghai Model Organisms Center, Inc.,
Zeclinics,
Ikan Biotech,
Charles River Laboratories,
Bioreperia,
Nordic Biomarker,
Vakona Ab,
Invivo Biosystems,
Biobide, Your Zebrafish Partner.
Invenesis's categories are Biotechnology Research
Invenesis's founding year is 2017
